NicOx announces agreement with GHO Capital to transfer commercial operations to new company July 5, 2016
TiGenix signs agreement with Takeda for Cx-601, withdraws ChondroCelect marketing authorization July 5, 2016
BIND Therapeutics files motion for court approval of Pfizer stalking horse asset purchase agreement July 4, 2016
Morphic Therapeutic completes series A financing to develop next-generation integrin therapies July 1, 2016
RSS